David Alfego

Chronic Kidney Disease Testing Among At-Risk Adults in the U.S. Remains Low: Real-World Evidence From a National Laboratory Database

David Alfego, Jennifer Ennis, Barbara S. Gillespie et al. · Diabetes Care · 2021 · 128 citations · Full text

Medicine, Nephrology, Health Assessment +16

A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States

David Alfego, Adam Sullivan, Brian Poirier et al. · EClinicalMedicine · 2021 · 121 citations · Full text

Public Health, Infectious Diseases, Population Health Sciences +13

PAPPA-mediated adipose tissue remodeling mitigates insulin resistance and protects against gestational diabetes in mice and humans

Raziel Rojas-Rodriguez, Rachel Ziegler, Tiffany DeSouza et al. · Science Translational Medicine · 2020 · 104 citations · Full text

Medicine, Endocrinology, Obstetrics +17

Balancing stealth and echogenic properties in an ultrasound contrast agent with drug delivery potential

Lauren J. Jablonowski, David Alfego, James I. Andorko et al. · Biomaterials · 2016 · 24 citations

Medicine, Biomedical Engineering, Pharmaceutics +16

Detection of Increased Activity of Human Parvovirus B19 Using Commercial Laboratory Testing of Clinical Samples and Source Plasma Donor Pools — United States, 2024

David Alfego, Alfonso C. Hernandez‐Romieu, Melissa Briggs‐Hagen et al. · MMWR Morbidity and Mortality Weekly Report · 2024 · 19 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17